Kobayashi Pharmaceutical Scandal Threatens 33,000 Japanese Enterprises
An investigation reveals that Kobayashi Pharmaceutical’s red yeast rice products may impact up to 33,000 enterprises in Japan, following health concerns and product recalls.
News & Insights Across Asia
An investigation reveals that Kobayashi Pharmaceutical’s red yeast rice products may impact up to 33,000 enterprises in Japan, following health concerns and product recalls.
Japanese health authorities are investigating Kobayashi Pharmaceutical’s factory amid deaths linked to their red yeast rice supplement. The probe seeks to uncover the cause behind the health issues.
Japanese authorities have investigated Kobayashi Pharmaceutical’s Osaka factory after a beni-koji supplement was linked to over 100 hospitalizations and five deaths.